How do investors and big pharma assess deals with startups and other companies? It isn't always an M&A, it could be an alliance, a licensing arrangement or some other form of partnership.

Anna Gran has worked in many roles in big pharma to spot these opportunities, using her deep science background and an MBA from the University of Cambridge Judge Business School. She will talk about these issues and share points about her career.

You need to watch this if you are in a startup in healthcare or biotech pitching to investors, or you are working in deeptech and thinking how to make a career switch to the business side, or you want to work in big pharma.